Hologic Announces Financial Results for Fourth Quarter of Fiscal 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Hologic (HOLX) Reports In-Line Q4 EPS, Offers FY and Q1 Guidance
November 6, 2019 4:59 PM ESTHologic (NASDAQ: HOLX) reported Q4 EPS of $0.65, in-line with the analyst estimate of $0.65. Revenue for the quarter came in at $865.8 million versus the consensus estimate of $845.73 million.
GUIDANCE:
Hologic sees FY2020 EPS of $2.60-$2.65, versus the consensus of $2.64. Hologic sees... More



